|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 41.92 USD | +0.19% |
|
+3.00% | -15.65% |
| 10-29 | Supernus Pharmaceuticals, Inc., Q3 2026 Earnings Call, Oct 29, 2026 | |
| 10-29 | Earnings Flash (SUPN) Supernus Pharmaceuticals Posts Q3 EPS $0.35, vs. FactSet Est of $0.08 Loss | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Specialty & Advanced Pharmaceuticals | +0.19% | +3.00% | -15.65% | -25.81% | +40.44% | 2.44B |  |  | |
- Stock Market
- Stocks
- SUPN Stock
- Charts Supernus Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
